US FDA Finds Pfizer’s COVID Vaccine For Kids 5-11 Worth The Risk Even In Lowest Incidence Model

 
• By Nielsen Hobbs

Overall benefit still favorable when there could be excess hospitalizations due to vaccine-related myocarditis because of ‘the different clinical implications of hospitalization for COVID-19,’ FDA concludes ahead of the advisory committee.

Three out of four shoes. Alamy-2BJ0G0H
Pfizer's vaccine fits FDA's COVID models almost every time, and success is basically in hand for the other one too, the agency concludes. • Source: Alamy

More from Vaccines

More from Pink Sheet